Patents Assigned to Aires Pharmaceuticals, Inc.
  • Patent number: 11219640
    Abstract: Disclosed herein are methods for treating acute or chronic heart failure using inorganic nitrite, such as sodium nitrite. The method includes administering to a subject in need of treatment a therapeutically effective amount of inorganic nitrite. The nitrite may be administered by inhalation and may be nebulized. The nitrite may be administered at an emitted dose or in an escalated titrated dose. The nitrite may be a liquid formulation or a dry powder formulation.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: January 11, 2022
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Aires Pharmaceuticals, Inc.
    Inventors: Mark Thomas Gladwin, Hunter Clay Champion, Edwin Parsley
  • Patent number: 9757411
    Abstract: Provided methods of administering poloxamer 188 for treating heart failure by only a single short relatively high dose infusion, or by regimen that includes the single infusion followed by additional infusions at intervals of 1-4 weeks.
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: September 12, 2017
    Assignee: Aires Pharmaceuticals, Inc.
    Inventors: R. Martin Emanuele, Santosh Vetticaden, Patrick Keran
  • Publication number: 20130028942
    Abstract: Disclosed herein are formulations of nitrite, nitrite salt, or nitrite- or nitric oxide-producing compounds suitable for aerosolization and use of such formulations for aerosol administration of nitrite, nitrite salt, or nitrite- or nitric oxide-donating compounds for the treatment of pulmonary arterial hypertension, intra-nasal or pulmonary bacterial infections, or to treat or prevent ischemic reperfusion injury of the heart, brain and organs involved in transplantation. In particular, inhaled nitrite, nitrite salt, or nitrite- or nitric oxide-donating compound specifically formulated and delivered to the respiratory tract for the indications is described. Compositions include all formulations, kits, and device combinations described herein. Methods include inhalation procedures and manufacturing processes for production and use of the compositions described.
    Type: Application
    Filed: September 25, 2012
    Publication date: January 31, 2013
    Applicant: AIRES PHARMACEUTICALS, INC.
    Inventor: AIRES PHARMACEUTICALS, INC.
  • Publication number: 20090196930
    Abstract: Disclosed herein are formulations of nitrite, nitrite salt, or nitrite- or nitric oxide-producing compounds suitable for aerosolization and use of such formulations for aerosol administration of nitrite, nitrite salt, or nitrite- or nitric oxide-donating compounds for the treatment of pulmonary arterial hypertension, intra-nasal or pulmonary bacterial infections, or to treat or prevent ischemic reperfusion injury of the heart, brain and organs involved in transplantation. In particular, inhaled nitrite, nitrite salt, or nitrite- or nitric oxide-donating compound specifically formulated and delivered to the respiratory tract for the indications is described. Compositions include all formulations, kits, and device combinations described herein. Methods include inhalation procedures and manufacturing processes for production and use of the compositions described.
    Type: Application
    Filed: December 24, 2008
    Publication date: August 6, 2009
    Applicant: Aires Pharmaceuticals, Inc.
    Inventors: Mark W. Surber, Gary T. Elliott, Geoffrey Eugene Barker